In addition, IL-2 treatment improves TME by promoting tumor infiltration by DCs and enhances sustained T-cell immunity against PDAC, whereas co-culture of IL-2 with PBMC significantly enhances the anti-tumor effects of DCs (75). This evidence concerns the gene IL2 and neoplasm.